26 February 2024 Insight Making the most of a better climate – biotech M&A in 2024 M&A transactions entered a period of unprecedented activity in 2021. As the era of uncertainty caused by the pandemic started to ease, deal volume and values exceeded expectations across the globe. Bookmark this page 5 min read
13 February 2024 Blog Disparaging the competition? Recent competition law investigations in the life sciences sector highlight the need for caution when making statements about a competitor's products. Share this article Bookmark this page 3 min read
12 February 2024 Insight Partnering, licensing and collaborations - issues and trends Our latest life sciences legal forum focused on partnering, licensing and research collaboration transactions. James Fry and Rebecca Auster addressed current issues and contracting themes from the perspective of reaching the deal, and managing common points of conflict between partners. Bookmark this page 4 min read
5 February 2024 Blog Intellectual property issues around use of AI in life sciences AI is increasingly being used across many sectors, including life sciences. Intellectual property expert Mark Pearce considers some of the current issues, around both protection of innovations and use of data resources. Share this article Bookmark this page 4 min read